United States Patent and Trademark Office
Susan Pocchiari has over fifteen years of experience providing counsel to clients in the biotechnology and biopharmaceutical industries on intellectual property matters. She has experience as both in-house intellectual property counsel as well as in private practice. In addition, Susan has a doctorate in the field of cancer immunology.
As in-house IP counsel at Boehringer Ingelheim, one of the top twenty pharmaceutical companies in the world, Dr. Pocchiari’s experience spanned a wide range of technical areas within the life sciences, including, for example, biotechnology, biochemistry, veterinary health, and pharmaceuticals.
Previously, Dr. Pocchiari was an associate at Pennie & Edmonds LLP, a large, New York City-based law firm that specialized in intellectual property. In private practice, she assisted a variety of clients ranging from startups to global corporations with the development and protection of intellectual property assets.
Dr. Pocchiari’s practice is focused on a wide array of specific technologies that have included therapeutic molecules, e.g., recombinant nucleic acids, proteins, peptides and antibodies, gene therapies, vaccines, and synthetic tissue scaffolds; transgenic animals; genomic and proteomic tools and assays; high-throughput screening assays; dietary supplements; medical diagnostics; and biopharmaceuticals.
Dr. Pocchiari received her J.D. from SUNY Buffalo Law School (1996) and her Ph.D. in microbiology and immunology from Roswell Park Cancer Institute, a division of SUNY Buffalo (1996).
She is admitted in practice in New York and the United States Patent and Trademark Office.